Padmesh S. Rajput, PhD

Padmesh S. Rajput, PhD





Padmesh S. Rajput, PhD

The research of Padmesh Rajput, PhD, focuses on translational and preclinical research to establish effective therapeutic approaches for stroke therapy, as well as determining the role of thrombin and thrombin receptors in pathophysiology of stroke. He is developing new therapeutic and diagnostic approaches using microRNA and exosomes in ischemia, as well as developing clinically relevant models of hypothermia therapy for stroke.

  • Master's: University of Hertfordshire, 2006
  • Doctorate: University of British Columbia, 2012
  • Ad-hoc Reviewer: Journal of Neurochemistry, 2013
  • Ad-hoc Reviewer: Translational Stroke Research, 2013
  • Ad-hoc Reviewer: Journal of Neurology and Neurophysiology, 2013
  • American Heart Association, 2013
  • Subhash C. Verma Memorial Prize in Pharmaceutical Sciences, 2009

Click here for a list of peer-reviewed publications.

  • Lapchak PA, Boitano PD, Butte PV, Fisher DJ, Hölscher T, Ley EJ, Nuño M, Voie AH, Rajput PS. Transcranial Near-Infrared Laser Transmission (NILT) profiles (800 nm): systematic comparison in four common research species. PLoS One. 2015;10(6):e0127580.
  • Rajput PS, Lyden PD, Chen B, Lamb J, Pereira B, Lamb A, Zhao L, Lei IF and Bai J. Protease activated receptor-1 mediates cytotoxicity during ischemia using in vivo and in vitro models. Neuroscience. 2014;281C:229-240.
  • Lyden PD, Pereira B, Chen B, Zhao L, Lamb J, Lie I, Rajput PS. Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models. Stroke. 2014;45(3):896-899.


Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.